UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019767
Receipt number R000022826
Scientific Title characteristics of body composition and physical function in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)
Date of disclosure of the study information 2015/11/14
Last modified on 2018/12/19 14:04:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

characteristics of body composition and physical function in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)

Acronym

physical function in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)

Scientific Title

characteristics of body composition and physical function in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)

Scientific Title:Acronym

physical function in patients with idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD)

Region

Japan


Condition

Condition

idiopathic pulmonary fibrosis
chronic obstructive pulmonary disease

Classification by specialty

Pneumology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

to explore a rehabilitation program specific to IPF by comparing body composition, physical function, physical activity, nutritional intake and muscle quality between patients with IPF and those with COPD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

muscle mass, fat mass
hand grip strength, knee extension strength
exercise tolerance
gait speed
balance ability
physical activity
nutritional intake
muscle thickness, muscle echo intensity

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

muscle ultrasonography once

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1.patients who are clinically diagnosed with IPF or with GOLD stage II-IV COPD
2.obtained written informed consent

Key exclusion criteria

1.patients with combined pulmonary fibrosis and emphysema or chronic respiratory disease except IPF and COPD
2.patients with low physical function due to cerebrovascular, neuromuscular and locomotor disease
3.patients with causative factors including severe edema and pacemaker or other metals in the body that influence on bioelectrical impedance analysis
4.patients with exacerbation within one month prior to enrollment
5.patients treated with oral corticosteroids
6.patients judged to be inappropriate for this study by investigators

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsushi Ishikawa

Organization

KKR Takamatsu Hospital

Division name

Rehabilitation Center

Zip code


Address

4-18 Tenjinmae, Takamatsu-shi, Kagawa-ken

TEL

087-861-3261

Email

a-ishikawa@kkr-ta-hp.gr.jp


Public contact

Name of contact person

1st name
Middle name
Last name Atsushi Isihikwa

Organization

KKR Takamatsu Hospital

Division name

Rehabilitation Center

Zip code


Address

4-18 Tenjinmae, Takamatsu-shi, Kagawa-ken

TEL

087-861-3261

Homepage URL


Email

a-ishikawa@kkr-ta-hp.gr.jp


Sponsor or person

Institute

KKR Takamatsu Hospital

Institute

Department

Personal name



Funding Source

Organization

KKR Takamatsu Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 16 Day

Date of IRB


Anticipated trial start date

2015 Year 11 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 12 Day

Last modified on

2018 Year 12 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022826


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name